| Medical and mental disorder: Proposed definition and criteria RL Spitzer, J Endicott, JAM Franchi Annales Médico-psychologiques, revue psychiatrique 176 (7), 656-665, 2018 | 213 | 2018 |
| Ketamine administration in depressive disorders: a systematic review and meta-analysis G Fond, A Loundou, C Rabu, A Macgregor, C Lançon, M Brittner, ... Psychopharmacology 231 (18), 3663-3676, 2014 | 197 | 2014 |
| EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials JA Micoulaud-Franchi, PA Geoffroy, G Fond, R Lopez, S Bioulac, P Philip Frontiers in human neuroscience 8, 906, 2014 | 121 | 2014 |
| Resting cortical PET metabolic changes in psychogenic non-epileptic seizures (PNES) M Arthuis, JA Micoulaud-Franchi, F Bartolomei, A McGonigal, E Guedj J Neurol Neurosurg Psychiatry 86 (10), 1106-1112, 2015 | 56 | 2015 |
| Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice JA Micoulaud-Franchi, A Mcgonigal, R Lopez, C Daudet, I Kotwas, ... Neurophysiologie Clinique/Clinical Neurophysiology 45 (6), 423-433, 2015 | 48 | 2015 |
| Risk of motor vehicle accidents related to sleepiness at the wheel: a systematic review and meta-analysis S Bioulac, JAM Franchi, M Arnaud, P Sagaspe, N Moore, F Salvo, P Philip Sleep 40 (10), 2017 | 41 | 2017 |
| Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample JA Micoulaud-Franchi, S Lagarde, G Barkate, B Dufournet, C Besancon, ... Epilepsy & Behavior 57, 211-216, 2016 | 35 | 2016 |
| One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E JA Micoulaud-Franchi, G Barkate, A Trébuchon-Da Fonseca, L Vaugier, ... Epilepsy & Behavior 44, 11-16, 2015 | 34 | 2015 |
| Neurofeedback: One of today's techniques in psychiatry? M Arns, JM Batail, S Bioulac, M Congedo, C Daudet, D Drapier, T Fovet, ... L'Encéphale 43 (2), 135-145, 2017 | 33 | 2017 |
| Skin conductance biofeedback training in adults with drug-resistant temporal lobe epilepsy and stress-triggered seizures: a proof-of-concept study JA Micoulaud-Franchi, I Kotwas, L Lanteaume, C Berthet, M Bastien, ... Epilepsy & Behavior 41, 244-250, 2014 | 33 | 2014 |
| Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study JA Micoulaud-Franchi, R Richieri, M Cermolacce, A Loundou, C Lancon, ... Journal of affective disorders 137 (1-3), 156-160, 2012 | 33 | 2012 |
| Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders P Alexis Geoffroy, B Etain, JA Micoulaud Franchi, F Bellivier, P Ritter Current pharmaceutical design 21 (23), 3352-3358, 2015 | 29 | 2015 |
| A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students JA Micoulaud-Franchi, A MacGregor, G Fond Eur Rev Med Pharmacol Sci 18 (13), 1875-8, 2014 | 29 | 2014 |
| The bidirectional relation between emotional reactivity and sleep: From disruption to recovery. E Altena, JA Micoulaud-Franchi, PA Geoffroy, E Sanz-Arigita, S Bioulac, ... Behavioral neuroscience 130 (3), 336, 2016 | 28 | 2016 |
| D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis D Ducasse, L Boyer, P Michel, A Loundou, A Macgregor, ... Psychopharmacology 231 (18), 3765-3770, 2014 | 28 | 2014 |
| (Mis) use of prescribed stimulants in the medical student community: motives and behaviors: a population-based cross-sectional study G Fond, M Gavaret, C Vidal, L Brunel, JP Riveline, JA Micoulaud-Franchi, ... Medicine 95 (16), 2016 | 27 | 2016 |
| Innovative mechanisms of action for pharmaceutical cognitive enhancement: a systematic review G Fond, JA Micoulaud-Franchi, L Brunel, A Macgregor, S Miot, R Lopez, ... Psychiatry research 229 (1-2), 12-20, 2015 | 24 | 2015 |
| Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory? JA Micoulaud-Franchi, WP Hetrick, M Aramaki, A Bolbecker, L Boyer, ... Schizophrenia research 157 (1-3), 157-162, 2014 | 24 | 2014 |
| Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set G Fond, O Godin, L Brunel, B Aouizerate, F Berna, E Bulzacka, ... Journal of affective disorders 191, 209-215, 2016 | 23 | 2016 |
| Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study M Faugere, JA Micoulaud-Franchi, M Alessandrini, R Richieri, ... Scientific reports 5, 10793, 2015 | 23 | 2015 |
Clélia QuilesVerified email at ch-perrens.fr
